Aspirin and sulfinpyrazone in threatened stroke
Completed
Phase N/A ResultsSummary of Purpose
To determine whether aspirin or sulfinpyrazone, singly or in combination, influence the subsequent occurrence of continuing transient ischemic attacks, stroke or death.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 7 March 2001.
Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Interventions
Sponsors
- Medical Research Council of Canada
Trial Design
Double-blind, randomized, stratified trial of 585 patients at 24 Canadian centers.
Contacts
Not available
Recruitment
- Gender: Both
- Study Size: 585
- Number of Centers: 24
- Max Time from Onset: 3 Months
- Follow Up: 26 Months
Principal Investigator
- H.J.M. Barnett
Locations
- Canada